Is Kenvue (KVUE) One of the Best High Volume Stocks to Buy According to Wall Street Analysts?

Kenvue Inc. (NYSE:KVUE)  is one of the best high volume stocks to buy according to Wall Street analysts. On October 10, JPMorgan lowered the price target on Kenvue to $21 from $24, while maintaining an Overweight rating on the shares as part of a Q3 2025 preview for the household, personal care, and beauty group. JPMorgan believes that most large-cap companies in the said group will report another weak quarter due to the depressed consumer demand in the US and decelerating trends for Western Europe. This backdrop is further worsened as retailers are actively reducing inventory as well.

Is Kenvue (KVUE) One of the Best High Volume Stocks to Buy According to Wall Street Analysts?

Earlier on October 9, Citi also lowered the firm’s price target on the company to $17 from $20, while keeping a Neutral rating on the shares due to a similar sentiment on the group. The firm sees a challenging backdrop for the beverage, household, and personal care group heading into Q3 as trends in the US remain soft.

Kenvue Inc. (NYSE:KVUE) operates as a consumer health company in the US, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health.

While we acknowledge the potential of KVUE to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than KVUE and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.